Trade rumors surrounded these pass catchers before. Will their teams finally pull the trigger on a move this year?

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today reported its business ...

As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...

In this piece, we will discuss the 10 Most Active Penny Stocks to Buy. The 2026 Iran conflict has resulted in a spike in ...

Pizza Hut Glasgow branch for sale in Penilee, leasehold with fixtures, offers over £120,000. Prime retail parade, strong ...

SEBI targets SPV status, borrowing ambiguity, and investment restrictions in REITs and InvITs. The reforms aim to enhance flexibility and market ...

Pi Network (PI) edges higher toward $0.1800 at press time on Thursday, as the mainnet upgrade to protocol 20 lays the ...

Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...

The Philippines’ balance of payments (BOP) swung to a deep deficit in February as capital outflows overwhelmed inflows, complicating the outlook for ...

Moore’s Law has shifted toward advanced packaging over the past few years, but the limits of that approach are just now coming into focus. AI and HPC designs are growing larger ...

First patent from a new patent family granted in China, strengthening the long‑term intellectual property protection for the Company’s lead product candidate.Oslo, Norway, 19 March 2026: Oncoinvent ...

Our result shows the detection of SVs from pre-treatment cfDNA using tumor-informed breakpoints-spanning ddPCR is feasible and may enable a novel and ...